Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jonas Bergh. (1995) High-Dose Therapy with Autologous Bone Marrow Stem Cell Support in Primary and Metastatic Human Breast Cancer. Acta Oncologica 34:5, pages 669-674.
Read now
Read now
Carl Blomqvist, Inkeri Elomaa, Pentti Rissanen, PÄIvi Hietanen, Kaisu Nevasaari & Leena Helle. (1992) FEC (5-Fluorouracil-Epirubicin-Cyclophosphamide) Monthly Versus FEC Weekly in Metastatic Breast Cancer: First results of a randomized trial. Acta Oncologica 31:2, pages 231-236.
Read now
Read now
Per Pfeiffer, SØRen Cold & Carsten Rose. (1992) Cytotoxic Treatment of Metastatic Breast Cancer: Which drugs and drug combinations to use?. Acta Oncologica 31:2, pages 219-224.
Read now
Read now
Stener Kvinnsland. (1992) Indications for Cytostatic Therapy in Metastatic Breast Cancer. Acta Oncologica 31:2, pages 215-218.
Read now
Read now
L. Bastholt & H. T. Mouridsen. (1990) How to Improve Cytotoxic Therapy in Advanced Breast Cancer. Acta Oncologica 29:3, pages 349-355.
Read now
Read now
H. T. Mouridsen, C. Alfthan, L. Bastholt, J. Bergh, M. Dalmark, S. Eksborg, S. Hellsten, M. Kjaer, C. Peterson, T. Skovsgård, J. B. Sørensen, C. Tropé & K. Aabo. (1990) Current Status of Epirubicin (Farmorubicin) in the Treatment of Solid Tumours. Acta Oncologica 29:3, pages 257-285.
Read now
Read now
K. Fischerman & H. T. Mouridsen. (1988) Danish Breast Cancer Cooperative Group (DBCG) Structure and results of the organization. Acta Oncologica 27:6, pages 593-596.
Read now
Read now
Articles from other publishers (11)
Mohan J. Roop, Baljinder Singh, Harmandeep Singh, Ankit Watts, Pavneet S. Kohli, Bhagwant R. Mittal & Gurpreet Singh. (2017) Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer. Clinical Nuclear Medicine 42:5, pages 335-340.
Crossref
Crossref
Sarah Barton & Charles Swanton. (2011) Recent Developments in Treatment Stratification for Metastatic Breast Cancer. Drugs 71:16, pages 2099-2113.
Crossref
Crossref
Miranda F. Ernst, Lonneke V. van de Poll-Franse, Jan A. Roukema, Jan Willem W. Coebergh, Cornelia M.J. van Gestel, Gerard Vreugdenhil, Marieke J. Louwman & Adri C. Voogd. (2007) Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002. The Breast 16:4, pages 344-351.
Crossref
Crossref
Joseph Sparano. 2002. Breast Cancer. Breast Cancer
417
472
.
F. Cardoso, A. Di Leo, C. Lohrisch, C. Bernard, F. Ferreira & M.J. Piccart. (2002) Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?. Annals of Oncology 13:2, pages 197-207.
Crossref
Crossref
Vicente Alonso, Carmen Santander, Jesús Florián, Martina Alonso, Ma Dolores Isla, Pilar Escudero, Alberto Sáenz & Alejandro Tres. (2018) Phase II Trial of Oral Tegafur and Folinic Acid with Mitoxantrone as First-Line Regimen in Patients with Metastatic Breast Cancer. Tumori Journal 82:1, pages 61-64.
Crossref
Crossref
C. Blomqvist, P. Hietanen, L. Teerenhovi & P. Rissanen. (1995) Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study. European Journal of Cancer 31:13-14, pages 2406-2408.
Crossref
Crossref
Nicholas J. Robert & Roy A. Beveridge. (1994) MANAGEMENT OF RECURRENT BREAST CANCER. Obstetrics and Gynecology Clinics of North America 21:4, pages 709-719.
Crossref
Crossref
Søren Cold, Niels V. Jensen, Hans Brincker & Carsten Rose. (1993) The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s. European Journal of Cancer 29:8, pages 1146-1152.
Crossref
Crossref
B. Ejlertsen, H.T Mouridsen, B. Kristensen, P. Pfeiffer, C. Rose, D. Pederson, M. Overgaard & E. Sandberg. (1993) Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months. European Journal of Cancer 29:4, pages 527-531.
Crossref
Crossref
H Joensuu & S Toikkanen. (1991) Comparison of breast carcinomas diagnosed in the 1980s with those diagnosed in the 1940s to 1960s.. BMJ 303:6795, pages 155-158.
Crossref
Crossref